Title for MeetingAbstracts

Alphabetical listing of titles

• Producing evidence-based guidance on cancer services: challenges and lessons.
• Producing physician administrators: an evaluation of medical school curricula and management education for physicians.
• Producing population-wide reductions in HIV risk behavior among small-city gay men: results of an experimental field trial in three cities.
• Production and characterization of a human-mouse chimeric monoclonal antibody (Cbeta1) against HIV.
• Production and characterization of core like particles (CLP) by expression of the HIV-1 gag gene in a Baculovirus system.
• Production and characterization of human immunodeficiency virus antigenic determinants and their use in diagnostics of AIDS.
• Production and characterization of monoclonal antibodies against HTLV-I core proteins.
• Production and characterization of purified gp120-CD4-CCR5 (CXCR4) complexes for use as HIV-1 vaccines and model systems.
• Production and Detection of Vascular Endothelial Growth Factor (VEGF) in Cerebrospinal Fluid (CSF) of AIDS Patients with Cryptococcal Meningitis.
• Production and distribution of 60.000 HIV/AIDS educational material to the professionals of the finantial sector.
• Production and immunomodulatory effects of IL-12 in HIV-infected infants.
• Production and purification of HIV integrase.
• Production and Purification of MraY, MurG and PBP1b, Essential Membrane Enzymes Involved in Peptidoglycan Synthesis.
• Production by in vitro immunization of human monoclonal antibodies against conserved regions of gp41.
• Production Efficiency of Medical Groups in the United States.
• Production of "venus fire" video on AIDS prevention among prostitutes in Rio de Janeiro.
• Production of a murine monoclonal antibody against Pneumocystis carinii.
• Production of adherent cell lines susceptible to lymphotropic viruses.
• Production of anti-HIV IGA by infant B cells.
• Production of beta-chemokines in HIV infection: levels of MIP-1 beta are predictive to the risk of HIV disease progression.
• Production of broad spectrum anti p24 monoclonals using bacterial expressed antigen.
• Production of C-C Chemokines by HIV-Infected Human Macrophages Stimulated with Cryptococcus neoformans and Its Cell Wall Component Glucuronoxylomannan (GXM).
• Production of chimeric virus-like particles containing the HIV-1 gag/pol and HIV-2 gag gene products.
• Production of defective HIV-1 in hollow fiber bioreactors.
• Production of genetically inactivated SIVsmmPBj14 viruslike particles for use as a potential vaccine.
• Production of Glucuronoxylomannan and other Phenotypes of Environmental Trichosporon asahii Isolates Are Changed by In Vivo Passage.
• Production of hematopoietic progenitor cells in long term bone marrow cultures infected with different isolates of HIV.
• Production of highly immunogenic recombinant HIV-1 integration protein (INT) by recombinant vaccinia virus and E. coli.
• Production of HIV (murine ecotropic retrovirus) pseudotypes for the development of murine animal models.
• Production of HIV DNA, mRNA and protein without infectious virus in growth-arrested cells.